Share the post "Chemfab Alkalis announced Financial Results Q1 2024"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company’s sales declined by -3.22 % over the year, decrease in net sales/revenue by -7.02 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -29.52 %, Marginal increase in other income during this quarter, up by 36.12%.
- Profit over the Year and quarter: Challenges in sustaining profitability for Chemfab Alkalis Limited. Profit dropped by -90.58 % Year to Year, Chemfab Alkalis Limited’s profitability dropped by -83.43 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -90.60 % Year to Year. EPS decreased by -83.42 % in previous quarter. Analysis needed for shareholder value.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 79.077 Cr | Rs. 82.308 Cr | Rs. 76.531 Cr | -7.02 % | -3.22 % |
Expenses | Rs. 63.59 Cr | Rs. 69.98 Cr | Rs. 68.2 Cr | -2.54 % | + 7.25 % |
Operating Profit | Rs. 15.49 Cr | Rs. 12.33 Cr | Rs. 8.33 Cr | -32.44 % | -46.22 % |
OPM % | 19.59 % | 14.98 % | 10.88 % | -4.1 % | -8.71 % |
Other Income | Rs. 3.679 Cr | Rs. 1.905 Cr | Rs. 2.593 Cr | + 36.12 % | -29.52 % |
Interest | Rs. 0.05 Cr | Rs. 0.41 Cr | Rs. 0.94 Cr | + 129.27 % | + 1780 % |
Depreciation | Rs. 5.42 Cr | Rs. 5.86 Cr | Rs. 7.31 Cr | + 24.74 % | + 34.87 % |
Profit before tax | Rs. 13.7 Cr | Rs. 7.97 Cr | Rs. 2.67 Cr | -66.5 % | -80.51 % |
Tax % | 30.6 % | 32.06 % | 66.49 % | + 34.43 % | + 35.89 % |
Net Profit | Rs. 9.51 Cr | Rs. 5.41 Cr | Rs. 0.9 Cr | -83.36 % | -90.54 % |
EPS in Rs | Rs. 6.63 | Rs. 3.76 | Rs. 0.62 | -83.51 % | -90.65 % |
Today, we’re looking at Chemfab Alkalis Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -3.22 %. However, it did see a marginal slip of -7.02 % from the previous quarter. Expenses decreased slightly by -2.54 % quarter-on-quarter, aligning with the annual rise of 7.25 %. Operating profit, while down -46.22 % compared to last year, faced a quarter-on-quarter dip of -32.44 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -8.71 %, but a shrinkage of -4.1 % sequentially. Other income rose by 36.12 % compared to the last quarter, despite an annual decline of -29.52 %. Interest expenses surged remarkably by 129.27 % from the previous quarter, yet the year-over-year increase remains at a moderate 1780 %. Depreciation costs climbed by 24.74 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 34.87 %. Profit before tax declined annually by -80.51 % but saw a reduction from the preceding quarter by -66.5 %.
Tax expenses as a percentage of profits increased slightly by 35.89 % compared to last year, with a more notable quarter-on-quarter increase of 34.43 %. Net profit fell by -90.54 % year-on-year but witnessed a -83.36 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -90.65 % but a quarterly fall of -83.51 %. In summary, Chemfab Alkalis Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 79.077 Cr | Rs. 82.308 Cr | Rs. 76.531 Cr | -7.02 % | -3.22 % |
Expenses | Rs. 63.59 Cr | Rs. 69.98 Cr | Rs. 68.2 Cr | -2.54 % | + 7.25 % |
Operating Profit | Rs. 15.49 Cr | Rs. 12.33 Cr | Rs. 8.33 Cr | -32.44 % | -46.22 % |
Net Profit | Rs. 9.51 Cr | Rs. 5.41 Cr | Rs. 0.9 Cr | -83.36 % | -90.54 % |
EPS in Rs | Rs. 6.63 | Rs. 3.76 | Rs. 0.62 | -83.51 % | -90.65 % |
In reviewing Chemfab Alkalis Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -3.22 % year-on-year, although there was a slight dip of -7.02 % from the previous quarter. Expenses rose by 7.25 % compared to the previous year, with a decrease of -2.54 % quarter-on-quarter. Operating Profit dropped by -46.22 % annually, and saw a -32.44 % decrease from the last quarter.
Net Profit showed yearly decrease of -90.54 %, and experienced a -83.36 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -90.65 % annually, however dipped by -83.51 % compared to the last quarter. In essence, while Chemfab Alkalis Limited faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
79
3-Year Profit
1
5-Year Profit
17
10-Year Profit
1,118
Current Price
1,598
Market Cap
The financial outlook for the company under BSE code 541269 reveals a significant five-year profit of 1 percents. This marks a notable increase to 79 percents over the last three years, indicating a strong upward trend in the company's financial health during this period. However, it's important to note that recent challenges have impacted the company's performance, leading to a trailing twelve-month loss of -53 percents. This sharp decline in profitability is particularly concerning, as the company has also reported no sales across any analyzed timeframe, suggesting a highly unconventional and perhaps risky operational approach. The company's stock prices mirror this financial volatility, with the stock trading at 43 percents over the past five years but experiencing a dramatic drop to 183 percents within the last year. Over a decade, the stock price was at 0 percents, reflecting long-term concerns regarding the company's stability and future outlook. Such performance poses questions about the sustainability of the business and whether it can rebound from these recent setbacks.
Currently valued at ₹1,598 crore, the company's stock price stands at ₹1,118. Over the years, it has seen significant fluctuations, with its price ranging from ₹1,230 / 336, a reflection of its sensitivity to market conditions and investor sentiment. The stock's Price-to-Earnings (P/E) ratio, currently at 90.2, suggests that it is highly valued in comparison to its earnings, possibly indicating strong future growth expectations or a high level of investor confidence. The book value per share is ₹272, which represents the net asset value of the company per share. The dividend yield of 0.11% provides some return to investors, though it may not be the primary attraction for those investing in the stock. The company's Return on Capital Employed (ROCE) is 10.2%, pointing to efficient use of its capital base to generate profits. The Return on Equity (ROE), at 6.75%, highlights the profitability for shareholders. The company's financial health is further underscored by its very low debt-to-equity ratio of 0.05, signaling conservative financial management. However, the net cash flow is negative at ₹-62.1 crore, indicating possible liquidity concerns or heavy investment. The Piotroski score of 4.00 provides a snapshot of its financial stability, while the Graham Number, estimated at ₹276, offers an intrinsic value benchmark. With a Price-to-Book (P/B) ratio of 4.11, the stock seems to be trading at a premium relative to its book value, which could signal strong market expectations or overvaluation risks.